AMG-193 is an oral, small-molecule, methylthioadenosine-cooperative inhibitor of the PRMT5 enzyme being developed by Amgen for the treatment of methylthioadenosine phosphorylase (MTAP)-null solid tumor indications. It is in early clinical evaluation for the treatment of various subtypes of MTAP-null advanced/metastatic solid tumors, including non-small cell lung cancer (NSCLC), pancreatic ductal adenocarcinoma (PDAC), gallbladder cancer and intra- or extrahepatic chloangiocarcinoma.
For research use only. We do not sell to patients.
Name | AMG-193 |
---|---|
Iupac Chemical Name | (4-Amino-1,3-dihydrofuro[3,4-c][1,7]naphthyridin-8-yl)[(3S)-3-[4-(trifluoromethyl)phenyl]morpholin-4-yl]methanone |
Synonyms | AMG-193 ; AMG193 ; AMG 193 |
Molecular Formula | C22H19F3N4O3 |
Molecular Weight | 444.406 |
Smile | O=C(C1=NC=C2N=C(N)C(COC3)=C3C2=C1)N4[C@@H](C5=CC=C(C(F)(F)F)C=C5)COCC4 |
InChiKey | BFEBTMFPRJPBTK-LJQANCHMSA-N |
InChi | InChI=1S/C22H19F3N4O3/c23-22(24,25)13-3-1-12(2-4-13)19-11-31-6-5-29(19)21(30)17-7-14-15-9-32-10-16(15)20(26)28-18(14)8-27-17/h1-4,7-8,19H,5-6,9-11H2,(H2,26,28)/t19-/m1/s1 |
CAS Number | 2790567-82-5 |
Related CAS | 2790567-82-5 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white to light-yellow solid |
---|---|
Purity | 98.62%; EE 98.28% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |